"山德士"艾如必注射劑1毫克/毫升

البلد: تايوان

اللغة: الصينية

المصدر: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

العنصر النشط:

IDARUBICIN HCL

متاح من:

台灣諾華股份有限公司 台北市中山區民生東路三段2號8樓 (01516589)

ATC رمز:

L01DB06

الشكل الصيدلاني:

注射劑

تركيب:

IDARUBICIN HCL (1003001110) MG

الوحدات في الحزمة:

玻璃小瓶裝;;盒裝

الفئة:

製　劑

نوع الوصفة الطبية :

限由醫師使用

المصنعة من قبل:

EBEWE PHARMA GMBH NFG. KG MONDSEESTRASSE 11, 4866 UNTERACH AM ATTERSEE, AUSTRIA AT

المجال العلاجي:

idarubicin

الخصائص العلاجية:

成人的急性非淋巴性白血病(ANLL)。成人與孩童的急性淋巴性白血病(ALL)。

ملخص المنتج:

註銷日期: 2021/09/11; 註銷理由: 自請註銷; 有效日期: 2024/07/15; 英文品名: Idarubicin Sandoz Concentrate for Solution for Infusion 1mg/ml

الوضع إذن:

已註銷

تاريخ الترخيص:

2019-07-15

نشرة المعلومات

xxxxxx-xx
Idarubicin Hydrochloride
(7
_S_
,9
_S_
)-9-acetyl-7,8,9,10-tetrahydro-6,7,9,11-tetrahydroxy-7-O-(2,3,6-trideoxy-3-
amino-α-L-lyxo-hexopyranosyl)-5,12-naphthacenedione hydrochloride
CAS57852-57-0
IDARUBICIN
anthracycline
IDARUBICIN
idarubicin hydrochloride
“” 1
Idarubicin Sandoz Concentrate for Solution for Infusion 1mg/ml
(Idarubicin Hydrochloride)
027704
Idarubicin
DNA
topoisomerase II
doxorubicin
daunorubicin
Idarubicin
daunorubicin
anthracycline
idarubicin
doxorubicin
daunorubicin
daunorubicin
doxorubicin
idarubicin
idarubicinol
idarubicinidarubicinol
idarubicin
10
35
Idarubicin
idarubicinol
41
69
Idarubicin
97%idarubicinol94%
idarubicin
Idarubicin
idarubicinol
100
Idarubicin
15
Idarubicinol72
idarubicinol
13 mg/m
2
14
C-idarubicin
14
33%
39%
idarubicin
2-7% idarubicinol
9-13%
517%(idarubicinidarubicinol)
Idarubicin
18% 39%
idarubicinol
(29-58%)
35%
(
)
Idarubicin
idarubicinol
200
Idarubicin
idarubicinol
idarubicin
idarubicin
<60/
idarubicin(AUC)38%idarubicinol AUC
120%
idarubicin
idarubicin
idarubicinol
idarubicin112
(ANLL)
(ALL)
IDARUBICIN
idarubicin
(
)
/
anthracycline
IDARUBICIN
idarubicin
/
anthracycline
anthracenedione
IDARUBICIN
IDARUBICIN
(
(
D))
IDARUBICIN
idarubicin
()
anthracycline
(
)
idarubicin
IDARUBICIN
idarubicin
/
idarubicin
idarubicin
IDARUBICIN
(
)
anthracycline
(
idarubicin)
(
)
DNA
anthracycline
13
/
(CHF)
150
290 mg/m
2
5%
idarubicin
IDARUBICIN
400 mg/m
2
(CHF)
anthracycline
(
)
()
Idarubicin
/
ECG
ST-T
(
)
2
3
(left
ventricular ejection fraction, LVEF)
/
(CHF)
(dependent oedema)
(gallop rhythm)
/
anthracycline
anthracycline
/
anthracycline
anthracenedione
(
trastuzumab)
Anthracycline
(
idarubicin)
(
)
(
trastuzumab)
anthracycline
Trastuzumab
28-38
27
trastuzumab
27
anthracycline
anthracycline
IDARUBICIN
/
(
/)
anthracycline
QRS
(PEP/LET)
(left ventricular ejection fraction, LVEF)
IDARUBICIN
(ECG)
(multiple
gated acquisition, MUGA)
(ECHO)
(LVEF
)
MUGA
ECHO
LVEF
anthracycline
idarubicin
(
)
Idarubicin
Idarubicin
(
)
allopurinol
IDARUBICIN
(
)
(
idarubicin)
idarubicin
idarubi